Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

28 Jun 2019 07:00

RNS Number : 7219D
DeepMatter Group PLC
28 June 2019
 

28 June 2019

DeepMatter Group plc

("DeepMatter", the "Company" or the "Group")

 

Directorate Change

 

As previously announced, DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitizing chemistry, is pleased to confirm the appointment of Lauren Lees to the Board as Financial Director with immediate effect.

 

Lauren is a chartered accountant who qualified with Grant Thornton UK LLP and has been Financial Controller at the Company since October 2018, during which time she has played a significant role in the strategic and operational development of the Group. Previously, she was Financial Controller at BioOutsource Limited, a high growth start-up life science company which was acquired by Sartorius AG in 2015, and then rebranded as Sartorius Stedim BioOutsource Limited, serving on both the local management and strategy teams. Lauren takes over as Financial Director from Michael Bretherton who has stepped down with immediate effect.

 

Lauren Rachel Lees, aged 31, holds no other current directorships, nor has she held a directorship during the five years prior to her appointment. She holds no interest in ordinary shares of the Company. There are no further disclosures to be made in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.

 

Mark Warne, Chief Executive Officer of DeepMatter, commented: 

 

"We are grateful for the significant contribution Michael has made to the business and wish him well in his future endeavours. We are also pleased to welcome Lauren to her new role as Financial Director. Her positive influence on not only the finance department, but also the broader Group so far has been significant, and we look forward to benefitting from her skills and experience further at Board level."

 

Ends

 

 

For further information:

 

DeepMatter Group plc

T: 0141 548 8156

Mark Warne, Chief Executive Officer

 

 

 

Shore Capital (Nominated Adviser and Broker)

T: 020 7601 6100

Tom Griffiths

David Coaten

 

 

 

Alma PR

Caroline Forde

Susie Hudson

Jessica Joynson

 

T: 020 3405 0209

deepmatter@almapr.co.uk

 

About DeepMatter:

 

DeepMatter's long term strategy is to integrate chemistry with technology, thereby enabling a greater use of artificial intelligence and reaching a point where chemicals can be autonomously synthesised through robotics. In the near term this involves the provision of an integrated software, hardware and artificial intelligence enabled platform, DigitalGlassware™, to scientists across research and process development sectors.

 

The DigitalGlassware™ platform allows chemistry experiments to be accurately and systematically recorded, coded and entered into a shared data cloud. The platform is designed to enable chemists to work together effectively; sharing the details of their experiments from anywhere and in real-time, so that work is not needlessly duplicated, time and money wasted, and ultimately so new discoveries may be made faster.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUCAQUPBGAM
Date   Source Headline
25th Jul 20084:44 pmRNSResult of AGM
30th Jun 20087:00 amRNSAudited Final Results
4th Jun 200812:50 pmRNSCollaborative Research and De
19th May 20082:07 pmRNSChange of Company Secretary a
15th Apr 200810:47 amRNSJoint Development Agreement
7th Apr 20083:52 pmRNSBusiness Update
28th Mar 200812:36 pmRNSHolding(s) in Company
17th Mar 20082:00 pmRNSHolding(s) in Company
5th Mar 20085:22 pmRNSAward of Share Options-Amend
3rd Mar 20081:23 pmRNSAward of Share Options
27th Feb 20087:01 amRNSAppointment of Director
11th Feb 200811:46 amRNSHolding(s) in Company
16th Jan 20081:52 pmRNSChange of Accounting Ref Date
10th Jan 200810:48 amRNSHolding(s) in Company
8th Jan 200811:46 amRNSHolding(s) in Company
31st Dec 20078:00 amRNSAdmission to AIM
27th Dec 200712:11 pmRNSHolding(s) in Company
21st Dec 20072:46 pmRNSGeneral Meeting
19th Dec 20078:00 amRNSShort Notice General Meeting
13th Dec 20072:36 pmRNSSchedule 1 - Kanyon plc
13th Dec 20071:39 pmRNSAdmission Document
12th Dec 20076:31 pmRNSAcquisition
25th Oct 20077:01 amRNSInterim Results
17th Aug 20077:01 amRNSAIM Rule 26 Website
29th Jun 20079:00 amRNSTotal Voting Rights
3rd May 200712:37 pmRNSAppointment of Directors
30th Apr 200710:15 amRNSEGM Statement
30th Apr 200710:08 amRNSAGM Statement
4th Apr 20072:48 pmRNSFinal Results
28th Mar 20071:44 pmRNSAcquisition
20th Dec 200611:53 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.